Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist Entity disclosure reporting period: 07/01/2019 - 12/31/2019

Authorizing Officer name	John F. Heffernan
Title	Principal
Business name	Park Street Strategies, LLC
Address	15 Clifton Avenue
City, state, zip code	Marblehead, MA 01945
Country	USA
Phone	617-981-0015

Client Compensation

Name	Amount
Biotechnology Innovation Organization (BIO)	$20,000.00
UCB, Inc.	$21,000.00
Massachusetts Biotechnology Council	$60,000.00
Shire	$0.00
Flexion Therapeutics, Inc.	$30,000.00
Total salaries received	$131,000.00

Compensation/Salaries Paid

Lobbyist or Entity name	Salaries
John F. Heffernan	$0.00
Total salaries paid	$0.00

Activities, Bill Numbers and Titles

No activities, bill numbers or bill titles were disclosed for this reporting period.

Operating Expenses

Date	Recipient	Type of expense	Amount
12/31/2019	Staple	Photocopies, scans	$73.86
07/18/2019	Greater Boston Chamber of Commerce	Professional dues	$350.00
12/31/2019	US Postal Service	Postage, shipping, delivery	$32.72
12/31/2019	Staple	Office supplies, equipment	$51.45
12/31/2019	Regus	Rent	$2,130.00
12/31/2019	AT&T	Telephone, cell phone, handheld	$676.38
10/17/2019	Boston Irish Business Association	Professional dues	$150.00
		Total operating expenses	$3,464.41

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.

Lobbyist: John F. Heffernan

Client: Biotechnology Innovation Organization (BIO)

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1133	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
House Bill	2666	An Act designating the last day of February as rare disease day in the Commonwealth	Neutral	$0.00	N/A
House Bill	4134	An Act to improve heath care by investing in VALUE	Neutral	$0.00	N/A
Senate Bill	652	An Act relative to pharmaceutical gag clauses	Support	$0.00	N/A
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	N/A
Senate Docket	2264	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	N/A
House Bill	229	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	N/A
House Bill	1154	An Act to reduce drug costs through transparency	Oppose	$0.00	N/A
House Bill	3500	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	N/A
House Bill	4268	Massachusetts rare disease advisory council	Neutral	$0.00	N/A
Senate Bill	654	An Act to strengthen pharmacy benefit management	Neutral	$0.00	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability	Neutral	$0.00	N/A
House Bill	1	making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	1148	An Act regarding Massachusetts drug price relief	Oppose	$0.00	N/A
House Bill	3481	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
House Bill	4228	Fail first and patient safety	Support	$0.00	N/A
Senate Bill	653	An Act relative to prescription drug pricing	Neutral	$0.00	N/A
Senate Bill	1295	An Act to reduce healthcare costs by promoting non-biased prescriber education	Oppose	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing	Neutral	$0.00	N/A
House Bill	1016	An Act establishing a commission to study maximum allowable costs lists	Neutral	$0.00	N/A
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	N/A
House Bill	1116	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	582	An Act ensuring access to medications	Neutral	$0.00	N/A
Senate Bill	733	An Act relative to consumer protection for prescription drug purchases	Support	$0.00	N/A
Senate Bill	2386	Senate FY 2019 Supplemental Budget (S2378, as amended)	Neutral	$0.00	N/A
House Bill	1062	An Act relative to transparent health care data	Neutral	$0.00	N/A
House Bill	1930	An Act providing for unused medication return by health care facilities	Neutral	$0.00	N/A
House Bill	4067	FY2019 Supplemental Budget - Governor	Neutral	$0.00	N/A
Senate Bill	611	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	N/A
Senate Bill	1206	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
Senate Bill	2409	Pharmaceutical Access, Costs and Transparency (Printed as Amended SB2397)	Oppose	$0.00	N/A
House Bill	1088	An Act relative to prescription drug access	Support	$0.00	N/A
House Bill	1934	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	N/A
House Bill	4127	FY2019 Supplemental Budget - House Ways and Means (Section 15 - Co-Pay assistance)	Support	$0.00	N/A
Senate Bill	640	An Act to ensure access to generic medications	Neutral	$0.00	N/A
Senate Bill	1218	An Act relative to sharps stewardship	Oppose	$0.00	N/A
Senate Bill	2418	Senate FY 2019 Supplemental Budget (new text for HB4132)	Neutral	$0.00	N/A
House Bill	391	An Act relative to reprogrammed human skin cells for embryonic stem cell research	Neutral	$0.00	N/A
House Bill	1660	An Act promoting pay transparency and pipeline advancement	Neutral	$0.00	N/A
House Bill	3551	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	3	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	695	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Oppose	$0.00	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs	Neutral	$0.00	N/A
House Bill	949	An Act relative to non-medical switching	Support	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Support	$0.00	N/A
House Bill	3877	Capping the price of life saving prescription drugs	Oppose	$0.00	N/A
Senate Bill	541	An Act relative to co-pay assistance	Support	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	2235	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	959	An Act requiring continual coverage of prescription medication	Neutral	$0.00	N/A
House Bill	1186	An Act strengthening HPC and CHIA market oversight	Neutral	$0.00	N/A
House Bill	988	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	543	An Act reducing health care costs through improved medication management	Support	$0.00	N/A
Senate Bill	715	An Act relative to pharmaceutical price transparency and cost sharing	Neutral	$0.00	N/A
Senate Bill	563	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
House Bill	915	An Act ensuring access to medications	Neutral	$0.00	N/A
House Bill	1167	An Act relative to prescription drug price transparency	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	154	An Act relative to bad faith assertions of patent infringement	Support	$0.00	N/A
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	N/A
Senate Bill	1780	An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax	Neutral	$0.00	N/A
House Bill	1055	An Act to ensure access to generic medications	Neutral	$0.00	N/A
House Bill	1860	An Act relative to the dispensing of prescription drugs	Neutral	$0.00	N/A
House Bill	4246	House FY 2019 Supplemental Budget	Neutral	$0.00	N/A
Senate Bill	601	An Act to reduce the cost of pharmacy benefits	Neutral	$0.00	N/A
Senate Bill	1149	An Act strengthening prescription drug safety and drug stewardship	Oppose	$0.00	N/A
Senate Bill	2397	Pharmaceutical Access, Costs and Transparency	Oppose	$0.00	N/A
House Bill	1013	An Act relative to pharmaceutical gag clauses	Support	$0.00	N/A
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Neutral	$0.00	N/A
House Bill	1050	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	570	An Act relative to out-of-pocket expenses for prescription drug coverage	Support	$0.00	N/A
Senate Bill	728	An Act providing affordable access to generic medicines	Neutral	$0.00	N/A
Senate Bill	2378	Senate FY 2019 Supplemental Budget	Neutral	$0.00	N/A
House Bill	916	An Act relative to co-pay assistance	Support	$0.00	N/A
House Bill	1168	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Neutral	$0.00	N/A
House Bill	3801	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	159	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Bill	1879	An Act to ensure more women serve on corporate boards of directors	Neutral	$0.00	N/A
House Bill	1111	An Act allowing for retail pharmacy discounts and co-pay assistance	Support	$0.00	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
House Bill	4132	House FY 2019 Supplemental Budget	Neutral	$0.00	N/A
Senate Bill	646	An Act to strengthen pharmacy benefit management	Neutral	$0.00	N/A
Senate Bill	1230	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	N/A
Senate Bill	2433	Step therapy and patient safety (new draft of S1235)	Support	$0.00	N/A
House Bill	966	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	N/A
House Bill	1192	An Act relative to the examination of health care cost trends in MassHealth	Neutral	$0.00	N/A
House Bill	1036	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	552	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	721	An Act relative to mandatory prescription drug coverage	Oppose	$0.00	N/A
Senate Bill	2338	Protect children, families, and firefighters from harmful flame retardants	Support	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	N/A
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
House Bill	3654	An Act relative to compensation for victims of opioids	Neutral	$0.00	N/A
Senate Bill	120	An Act relative to consumer data privacy	Neutral	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	1701	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Oppose	$0.00	N/A
House Bill	4000	An Act making appropriations for fiscal year 2020	Neutral	$0.00	N/A
			Total amount	$0.00

Lobbyist: John F. Heffernan

Client: UCB, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	N/A
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	N/A
House Bill	949	An Act relative to non-medical switching	Support	$0.00	N/A
House Bill	4246	An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects	Neutral	$0.00	N/A
House Bill	3801	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	2235	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
House Bill	1145	An Act relative to the treatment of epilepsy and seizure disorders	Support	$0.00	N/A
House Bill	4132	An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects	Neutral	$0.00	N/A
			Total amount	$0.00

Lobbyist: John F. Heffernan

Client: Massachusetts Biotechnology Council

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	391	An Act relative to reprogrammed human skin cells for embryonic stem cell research	Neutral	$0.00	N/A
House Bill	1660	An Act promoting pay transparency and pipeline advancement	Neutral	$0.00	N/A
House Bill	3877	Capping the price of life saving prescription drugs	Oppose	$0.00	N/A
Senate Bill	541	An Act relative to co-pay assistance	Support	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	2235	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	915	An Act ensuring access to medications	Neutral	$0.00	N/A
House Bill	1167	An Act relative to prescription drug price transparency	Oppose	$0.00	N/A
House Bill	1036	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	552	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	721	An Act relative to mandatory prescription drug coverage	Oppose	$0.00	N/A
Senate Bill	2338	Protect children, families, and firefighters from harmful flame retardants	Support	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	N/A
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
House Bill	988	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	543	An Act reducing health care costs through improved medication management	Support	$0.00	N/A
Senate Bill	715	An Act relative to pharmaceutical price transparency and cost sharing	Neutral	$0.00	N/A
Senate Bill	563	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
House Bill	1088	An Act relative to prescription drug access	Support	$0.00	N/A
House Bill	1934	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	N/A
House Bill	3500	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	N/A
House Bill	4268	Massachusetts rare disease advisory council	Neutral	$0.00	N/A
Senate Bill	654	An Act to strengthen pharmacy benefit management	Neutral	$0.00	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability	Neutral	$0.00	N/A
House Bill	1133	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
House Bill	2666	An Act designating the last day of February as rare disease day in the Commonwealth	Neutral	$0.00	N/A
House Bill	3654	An Act relative to compensation for victims of opioids	Neutral	$0.00	N/A
Senate Bill	120	An Act relative to consumer data privacy	Neutral	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	1701	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Oppose	$0.00	N/A
House Bill	4000	An Act making appropriations for fiscal year 2020	Neutral	$0.00	N/A
House Bill	1	making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	1148	An Act regarding Massachusetts drug price relief	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	154	An Act relative to bad faith assertions of patent infringement	Support	$0.00	N/A
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	N/A
Senate Bill	1780	An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax	Neutral	$0.00	N/A
House Bill	916	An Act relative to co-pay assistance	Support	$0.00	N/A
House Bill	1168	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Neutral	$0.00	N/A
House Bill	1050	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	570	An Act relative to out-of-pocket expenses for prescription drug coverage	Support	$0.00	N/A
Senate Bill	728	An Act providing affordable access to generic medicines	Neutral	$0.00	N/A
Senate Bill	2338	Senate FY 2019 Supplemental Budget	Neutral	$0.00	N/A
House Bill	1013	An Act relative to pharmaceutical gag clauses	Support	$0.00	N/A
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Neutral	$0.00	N/A
House Bill	4127	FY2019 Supplemental Budget - House Ways and Means (Section 15 - Co-Pay assistance)	Support	$0.00	N/A
Senate Bill	640	An Act to ensure access to generic medications	Neutral	$0.00	N/A
Senate Bill	1218	An Act relative to sharps stewardship	Oppose	$0.00	N/A
Senate Bill	2418	Senate FY 2019 Supplemental Budget (new text for HB4132)	Neutral	$0.00	N/A
House Bill	1016	An Act establishing a commission to study maximum allowable costs lists	Neutral	$0.00	N/A
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	N/A
House Bill	4132	House FY 2019 Supplemental Budget	Neutral	$0.00	N/A
Senate Bill	646	An Act to strengthen pharmacy benefit management	Neutral	$0.00	N/A
Senate Bill	1230	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	N/A
Senate Bill	2433	Step therapy and patient safety (new draft of S1235)	Support	$0.00	N/A
House Bill	959	An Act requiring continual coverage of prescription medication	Neutral	$0.00	N/A
House Bill	1186	An Act strengthening HPC and CHIA market oversight	Neutral	$0.00	N/A
House Bill	4246	House FY 2019 Supplemental Budget	Neutral	$0.00	N/A
Senate Bill	601	An Act to reduce the cost of pharmacy benefits	Neutral	$0.00	N/A
Senate Bill	1149	An Act strengthening prescription drug safety and drug stewardship	Oppose	$0.00	N/A
Senate Bill	2397	Pharmaceutical Access, Costs and Transparency	Oppose	$0.00	N/A
House Bill	1111	An Act allowing for retail pharmacy discounts and co-pay assistance	Support	$0.00	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
House Bill	3551	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	3	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	695	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Oppose	$0.00	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs	Neutral	$0.00	N/A
House Bill	1062	An Act relative to transparent health care data	Neutral	$0.00	N/A
House Bill	1930	An Act providing for unused medication return by health care facilities	Neutral	$0.00	N/A
House Bill	3481	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
House Bill	4228	Fail first and patient safety	Support	$0.00	N/A
Senate Bill	653	An Act relative to prescription drug pricing	Neutral	$0.00	N/A
Senate Bill	1295	An Act to reduce healthcare costs by promoting non-biased prescriber education	Oppose	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing	Neutral	$0.00	N/A
House Bill	966	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	N/A
House Bill	1192	An Act relative to the examination of health care cost trends in MassHealth	Neutral	$0.00	N/A
House Bill	4067	FY2019 Supplemental Budget - Governor	Neutral	$0.00	N/A
Senate Bill	611	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	N/A
Senate Bill	1206	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
Senate Bill	2409	Pharmaceutical Access, Costs and Transparency (Printed as Amended SB2397)	Oppose	$0.00	N/A
House Bill	229	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	N/A
House Bill	1154	An Act to reduce drug costs through transparency	Oppose	$0.00	N/A
House Bill	3801	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	159	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Bill	1879	An Act to ensure more women serve on corporate boards of directors	Neutral	$0.00	N/A
House Bill	1055	An Act to ensure access to generic medications	Neutral	$0.00	N/A
House Bill	1860	An Act relative to the dispensing of prescription drugs	Neutral	$0.00	N/A
House Bill	4134	An Act to improve heath care by investing in VALUE	Neutral	$0.00	N/A
Senate Bill	652	An Act relative to pharmaceutical gag clauses	Support	$0.00	N/A
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	N/A
Senate Docket	2264	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	N/A
House Bill	949	An Act relative to non-medical switching	Support	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Support	$0.00	N/A
House Bill	1116	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	N/A
Senate Bill	582	An Act ensuring access to medications	Neutral	$0.00	N/A
Senate Bill	733	An Act relative to consumer protection for prescription drug purchases	Support	$0.00	N/A
Senate Bill	2386	Senate FY 2019 Supplemental Budget (S2378, as amended)	Neutral	$0.00	N/A
			Total amount	$0.00

Lobbyist: John F. Heffernan

Client: Flexion Therapeutics, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Executive	Department of Public Health (DPH)	Monitoring Department of Public Health opioid regulations	Neutral	$0.00	N/A
House Bill	3801	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	2235	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

Date	Lobbyist name	Event type	Payee/Vendor	Attendees	Amount
07/23/2019	John F. Heffernan	Meal	Capital Coffee House	John F. Heffernan;Robert Coughlin	$13.39
09/25/2019	John F. Heffernan	Meal	Legal Harborside	John F. Heffernan;Pat Cerundolo	$43.73
07/25/2019	John F. Heffernan	Meal	State Street Provisions	John F. Heffernan;William McDermott	$119.51
11/22/2019	John F. Heffernan	Travel	MBTA Parrking	John F. Heffernan	$2.00
12/16/2019	John F. Heffernan	Travel	MBTA Parking	John F. Heffernan	$2.00
07/25/2019	John F. Heffernan	Travel	Passport Parking	John F. Heffernan	$2.15
12/17/2019	John F. Heffernan	Travel	City of Cambridge Parking	John F. Heffernan	$3.50
07/30/2019	John F. Heffernan	Travel	OPC Parking, Boston	John F. Heffernan	$4.15
07/30/2019	John F. Heffernan	Travel	OPC Parking, Boston	John F. Heffernan	$5.15
07/25/2019	John F. Heffernan	Travel	MBTA	John F. Heffernan	$8.00
07/29/2019	John F. Heffernan	Travel	Uber, from State House to 300 Technology Sq, Campbridge	John F. Heffernan;Susan Martin;Zach Stanley	$8.24
10/21/2019	John F. Heffernan	Travel	Uber, from State House to 300 Technology Square, Cambridge	John F. Heffernan;Susan Martin;William McDermott	$8.95
07/29/2019	John F. Heffernan	Travel	Uber, from 300 Technology Sq, Campbridge to State House	John F. Heffernan;Susan Martin;Zach Stanley	$10.25
11/18/2019	John F. Heffernan	Travel	100 Cambridge Street Parking	John F. Heffernan	$38.00
11/18/2019	John F. Heffernan	Travel	Technology Square Parking	John F. Heffernan;Susan Martin	$38.00
08/27/2019	John F. Heffernan	Travel	PO Square Parking	John F. Heffernan	$40.00
08/29/2019	John F. Heffernan	Travel	Technology Square Parking	John F. Heffernan;Susan Martin;Robert Coughlin	$40.00
10/17/2019	John F. Heffernan	Travel	PO Square Parking	John F. Heffernan	$40.00
				Total amount	$427.02

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Lobbyist name	Recipient name	Office sought	Amount
07/02/2019	John F. Heffernan	Committee for a Democratic Senate	State Party Committee	$200.00
07/09/2019	John F. Heffernan	Robert DeLeo	State Representative	$200.00
07/09/2019	John F. Heffernan	Denise Garlick	State Representative	$200.00
07/16/2019	John F. Heffernan	Joseph Boncore	State Senate	$200.00
08/08/2019	John F. Heffernan	Committee for a Democratic House	State Party Committee	$200.00
08/27/2019	John F. Heffernan	Ann Margaret Ferrante	State Representative	$200.00
09/10/2019	John F. Heffernan	John Santiago	State Representative	$200.00
10/15/2019	John F. Heffernan	Barry Finegold	State Senate	$200.00
10/17/2019	John F. Heffernan	Joseph Wagner	State Representative	$200.00
10/17/2019	John F. Heffernan	Julian Cyr	State Senate	$200.00
10/29/2019	John F. Heffernan	Brendan Crighton	State Senate	$200.00
11/14/2019	John F. Heffernan	John Lawn	State Representative	$200.00
11/17/2019	John F. Heffernan	Lori Ehrlich	State Representative	$200.00
11/19/2019	John F. Heffernan	Daniel Cullinane	State Representative	$200.00
11/20/2019	John F. Heffernan	Nick Collins	State Senate	$200.00
			Total contributions	$3,000.00

Close this page

Connect with Us